Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.07

-0.01 (-0.93%)

As of Nov 13, 2:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +2,708.4% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $1.07

Current
$1.07

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

1,967.3%

Low target

Base Case

$30.05

+2,708.4%

Avg target

Bull Case

$38.96

+3,541.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-75.3% from high

52-Week Low

$0.94

+13.8% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%